una vista de el manejo de el dolor desde el punto de vista anestésico, mejoría en tratamiento y prevención de dolor en pacientes obstétricas, anestesia multimodal.
RES5153 Mod 5 Application Reflection
Research project to discover solutions about AVID students who do not fulfill their responsibility of participating in community service activities.
RES5153 Mod 5 Application Reflection
Research project to discover solutions about AVID students who do not fulfill their responsibility of participating in community service activities.
Būsto mugė - Investavimas į NT ir trumpalaikė nuoma Vilniuje - ką įsigy...Tomas Grizas
Pavasarinėje Lietuvos nekilnojamojo turto asociacijos organizuotoje Būsto mugėje pristačiau pranešimą tema "Investavimas į NT ir trumpalaikė nuoma: ką įsigyti šiandien, kad atsipirktų rytoj?"
República bolivariana de Venezuela
Ministerio del poder popular para la educación
Universidad politécnico territorial Andrés Eloy blanco
Pnf higiene y seguridad laboral
Autor:
Méndez yépez, Isaías Omar
Ci 28.466.887
Profesor:ing.segueri, larry
Cátedra: matemática, grupo b
Peter Sarlin, Silo AI
FIN-FSA's annual conference on 22 November 2017: Financial Services 2022 – How will financial services develop in the next few years?
Ha a pénzedet nem tudod befektetni, a kreativitásodat kell!
Ebben az élő adásban olyan kreatív, szokatlan, figyelemfelkeltő ötleteket mutatok majd, amikkel megfoghatod az emberek figyelmét, felhívhatod a figyelmet a portékádra és ami a legfontosabb: megszerezheted az első vevőidet anélkül, hogy egyetlen fillért is költöttél volna hirdetésekre!
The SlideShare on Oral Cavity Problems is a concise and informative presentation covering a wide range of oral health issues, including tooth decay, gum disease, oral cancer, and other conditions that can affect the mouth. The presentation explains the causes, symptoms, and treatment options for each of these problems, while emphasizing the importance of good oral hygiene and regular dental check-ups. Illustrated with diagrams and images, this SlideShare is suitable for anyone interested in learning more about oral health and the common problems that can arise in the oral cavity.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Būsto mugė - Investavimas į NT ir trumpalaikė nuoma Vilniuje - ką įsigy...Tomas Grizas
Pavasarinėje Lietuvos nekilnojamojo turto asociacijos organizuotoje Būsto mugėje pristačiau pranešimą tema "Investavimas į NT ir trumpalaikė nuoma: ką įsigyti šiandien, kad atsipirktų rytoj?"
República bolivariana de Venezuela
Ministerio del poder popular para la educación
Universidad politécnico territorial Andrés Eloy blanco
Pnf higiene y seguridad laboral
Autor:
Méndez yépez, Isaías Omar
Ci 28.466.887
Profesor:ing.segueri, larry
Cátedra: matemática, grupo b
Peter Sarlin, Silo AI
FIN-FSA's annual conference on 22 November 2017: Financial Services 2022 – How will financial services develop in the next few years?
Ha a pénzedet nem tudod befektetni, a kreativitásodat kell!
Ebben az élő adásban olyan kreatív, szokatlan, figyelemfelkeltő ötleteket mutatok majd, amikkel megfoghatod az emberek figyelmét, felhívhatod a figyelmet a portékádra és ami a legfontosabb: megszerezheted az első vevőidet anélkül, hogy egyetlen fillért is költöttél volna hirdetésekre!
The SlideShare on Oral Cavity Problems is a concise and informative presentation covering a wide range of oral health issues, including tooth decay, gum disease, oral cancer, and other conditions that can affect the mouth. The presentation explains the causes, symptoms, and treatment options for each of these problems, while emphasizing the importance of good oral hygiene and regular dental check-ups. Illustrated with diagrams and images, this SlideShare is suitable for anyone interested in learning more about oral health and the common problems that can arise in the oral cavity.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Anestesia multimodal, una vista hacia la Ginecología.pptx
1.
1 3 / 0 7 / 2 0 2 3 U R U A P A N M I C H O A C Á N . 1
2.
1 / 3 / 2 0 X X E J E M P L O D E T E X T O D E P I E D E P Á G I N A 2
3. G Ó M E Z C O A , G A R C Í A S L S . M A N E J O D E L D O L O R P O S T O P E R A T O R I O
E N C I R U G Í A P O R C Á N C E R D E M A M A . A C T A M E D . 2 0 2 2 ; 2 0 ( 1 ) : 5 8 -
6 1 . D O I : 1 0 . 3 5 3 6 6 / 1 0 3 5 5 7 . 3
4.
1 3 / 0 7 / 2 0 2 3
R E V I S T A O C R O N O S . V O L . I V . N º 9 – S E P T I E M B R E 2 0 2 1 .
P Á G . I N I C I A L : V O L . I V ; N º 9 : 1 5 4 4
7. 1 3 / 0 7 / 2 0 2 3
G Ó M E Z C O A , G A R C Í A S L S . M A N E J O D E L D O L O R
P O S T O P E R A T O R I O E N C I R U G Í A P O R C Á N C E R D E M A M A . A C T A
M E D G A . 2 0 2 2 ; 2 0 ( 1 ) : 5 8 - 6 1 .
H T T P S : / / D X . D O I . O R G / 1 0 . 3 5 3 6 6 / 1 0 3 5 5 7
7
8.
1 3 / 0 7 / 2 0 2 3
I N C L U I D O E N L A R E V I S T A O C R O N O S . V O L . I V . N º 9 –
S E P T I E M B R E 2 0 2 1 . P Á G . I N I C I A L : V O L . I V ; N º 9 : 1 5 4 . 8
9. 1 3 / 0 7 / 2 0 2 3
G Ó M E Z C O A , G A R C Í A S L S . M A N E J O D E L D O L O R
P O S T O P E R A T O R I O E N C I R U G Í A P O R C Á N C E R D E M A M A . A C T A
M E D G A . 2 0 2 2 ; 2 0 ( 1 ) : 5 8 - 6 1 .
H T T P S : / / D X . D O I . O R G / 1 0 . 3 5 3 6 6 / 1 0 3 5 5 7
9
10. 1 3 / 0 7 / 2 0 2 3
R O S A - D Í A Z J , N A V A R R E T E - Z U A Z O V , D I A Z - M E N D I O N D O M . A S P E C T O S
B Á S I C O S D E L D O L O R P O S T O P E R A T O R I O Y L A A N A L G E S I A M O D A L
P R E V E N T I V A . R E V M E X A N E S T E S I O L . 2 0 1 4 ; 3 7 ( 1 ) : 1 8 - 2 6
1 0
11. 1 3 / 0 7 / 2 0 2 3
Y O U N G A , B U V A N E N D R A N A . R E C E N T A D V A N C E S I N M U L T I M O D A L
A N A L G E S I A . A N E S T H E S I O L C L I N . 2 0 1 2 ; 3 0 ( 1 ) : 9 1 - 1 0 0 .
1 1
12. 1 / 3 / 2 0 X X E J E M P L O D E T E X T O D E P I E D E P Á G I N A 1 2
13. 1 3 / 0 7 / 2 0 2 3
Y O U N G A , B U V A N E N D R A N A . R E C E N T A D V A N C E S I N
M U L T I M O D A L A N A L G E S I A . A N E S T H E S I O L C L I N .
2 0 1 2 ; 3 0 ( 1 ) : 9 1 - 1 0 0 .
1 3
15. 1 3 / 0 7 / 2 0 2 3
T O R N E R O C , F E R N Á N D E Z L E , O R D U Ñ A J . A N A L G E S I A M U L T I M O D A L Y
A N E S T E S I A R E G I O N A L . R E V E S P A N E S T E S I O L R E A N I M . 2 0 1 7 ; 6 4 ( 7 ) : 4 0 1 - 4 0 5 .
1 5
16. 1 3 / 0 7 / 2 0 2 3 1 6
ARN BSA o
Epidural
combinado
con sedación /
o AGB O
AGEV
AL + Sedación
y/o AGB/
ATEV.
AGB/ATEV +
ARP O ARN
21.
1 3 / 0 7 / 2 0 2 3
D O M . C I E N . , I S S N : 2 4 7 7 - 8 8 1 8 V O L . 8 , N Ú M . 1 , E N E R O -
M A R Z O 2 0 2 2 , P P . 4 0 3 - 4 1 3
2 1
22. 1 3 / 0 7 / 2 0 2 3
D O M . C I E N . , I S S N : 2 4 7 7 - 8 8 1 8 V O L . 8 , N Ú M . 1 , E N E R O -
M A R Z O 2 0 2 2 , P P . 4 0 3 - 4 1 3 2 2
23. 1.
2.
3.
4.
5.
1.
2.
3.
1.
2.
3.
1 3 / 0 7 / 2 0 2 3
R O D R Í G U E Z , G . , C A M A C H O , F . , & U M A Ñ A , C . ( 2 0 2 0 ) .
A N A L G E S I A O B S T É T R I C A P A R A E L P A R T O V A G I N A L :
E F I C A C I A Y E F E C T O S A D V E R S O S . R E V I S T A M É D I C A
S I N E R G I A . V O L . 5 N U M : 1 .
2 3
24. 1 3 / 0 7 / 2 0 2 3
D O M . C I E N . , I S S N : 2 4 7 7 - 8 8 1 8 V O L . 8 , N Ú M . 1 , E N E R O -
M A R Z O 2 0 2 2 , P P . 4 0 3 - 4 1 3
2 4
25.
1 3 / 0 7 / 2 0 2 3
D O M . C I E N . , I S S N : 2 4 7 7 - 8 8 1 8 V O L . 8 , N Ú M . 1 , E N E R O -
M A R Z O 2 0 2 2 , P P . 4 0 3 - 4 1 3 2 5
26.
1 3 / 0 7 / 2 0 2 3
D O M . C I E N . , I S S N : 2 4 7 7 - 8 8 1 8 V O L . 8 , N Ú M . 1 , E N E R O -
M A R Z O 2 0 2 2 , P P . 4 0 3 - 4 1 3 2 6
27. 1 3 / 0 7 / 2 0 2 3 2 7
Disminuir los riesgos de efectos adversos de los fármacos, y
tener un mejor resultado en manejo de dolor.
Dismuir el tiempo de internamiento de los pacientes, para
prevenir complicaciones nosocomiales.
Tener en cuenta que cada paciente y sus necesidades son
diferentes.
29. 1. Rosa-Díaz J, Navarrete-Zuazo V, Diaz-Mendiondo M. Aspectos básicos del dolor postoperatorio y la analgesia modal
preventiva. Rev Mex Anestesiol. 2014;37(1):18-26.
2. Mugabure B, Tranque I, González S, Adrián R. Estrategias para el abordaje multimodal del dolor y de la recuperación
postoperatoria. Rev Esp Anestesiol Reanim. 2007;54:29-40.
3. Young A, Buvanendran A. Recent Advances in Multimodal Analgesia. Anesthesiol Clin. 2012;30(1):91-100.
4. Català E, Moral MV. Dolor agudo postoperatorio. La necesidad de su correcto tratamiento. Cir Esp. 2009;86(2):61-62.
5. Santeularia MT, Català E, Genové M, Revuelta M, Moral MV. Nuevas tendencias en el tratamiento del dolor
postoperatorio en cirugía general y digestiva. Cir Esp. 2009;86(2):63-71.
6. Tornero C, Fernández LE, Orduña J. Analgesia multimodal y anestesia regional. Rev Esp Anestesiol Reanim.
2017;64(7):401-405.
7. Matute M, Montero A. Avances farmacológicos en el manejo multimodal de la analgesia postoperatoria. Rev Esp
Anestesiol Reanim. 2017;64(8):467-471.
1 / 3 / 2 0 X X E J E M P L O D E T E X T O D E P I E D E P Á G I N A 2 9
